Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

被引：0

作者：

Majid Malekmohammad

Gert Folkerts

Babak Sharif Kashani

Parisa Adimi Naghan

Zahra Habibi Dastenae

Batoul Khoundabi

Johan Garssen

Esmaeil Mortaz

Ian M. Adcock

机构：

[1] Tracheal Disease Research Center,Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science

[2] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined

[3] Shahid Beheshti University of Medical Sciences,undefined

[4] Utrecht University,undefined

[5] Chronic Respiratory Diseases Research Center,undefined

[6] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined

[7] Shahid Beheshti University of Medical Sciences,undefined

[8] Helal-e-Iran Applied Science Higher Education Institute Red crescents society of Iran,undefined

[9] Clinical Tuberculosis and Epidemiology Research Center,undefined

[10] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined

[11] Shahid Beheshti University of Medical Sciences,undefined

[12] Cell and Molecular Biology Group,undefined

[13] Airways Disease Section,undefined

[14] Faculty of Medicine,undefined

[15] National Heart and Lung Institute,undefined

[16] Imperial College London,undefined

[17] Priority Research Centre for Asthma and Respiratory Disease,undefined

[18] Hunter Medical Research Institute,undefined

[19] University of Newcastle,undefined

来源：

BMC Pulmonary Medicine | / 19卷

关键词：

FeNO; Hypertention; Lungs; Exhaled nitric oxide;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Effect of medroxyprogesterone on pulmonary arterial pressure, exhaled nitric oxide, ECG and arterial blood gases
Saaresranta, T
Uotila, P
Saraste, M
Irjala, K
Hartiala, J
Polo, O
JOURNAL OF INTERNAL MEDICINE, 2002, 251 (05) : 421 - 428
[32] Inhaled nitric oxide: a more physiological treatment or persistent pulmonary arterial hypertension in the newborn
Thebaud, B
Mercier, JC
ARCHIVES DE PEDIATRIE, 1997, 4 (10): : 988 - 1003
[33] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
M J Garabedian
W F Hansen
E A Gianferrari
K Y Lain
R Y Fragneto
C L Campbell
D C Booth
Journal of Perinatology, 2010, 30 : 628 - 631
[34] Guidelines for Treatment of Idiopathic/Heritable Pulmonary Arterial Hypertension
Ogo, Takeshi
JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S124 - S124
[35] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
Garabedian, M. J.
Hansen, W. F.
Gianferrari, E. A.
Lain, K. Y.
Fragneto, R. Y.
Campbell, C. L.
Booth, D. C.
JOURNAL OF PERINATOLOGY, 2010, 30 (09) : 628 - 631
[36] Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis
Cameli, Paolo
Bergantini, Laura
Salvini, Martina
Refini, Rosa Metella
Pieroni, Maria
Bargagli, Elena
Sestini, Piersante
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2019, 89 : 41 - 45
[37] Exhaled nitric oxide in systemic sclerosis: Relationships with lung involvement and pulmonary hypertension
Rolla, G
Colagrande, P
Scappaticci, E
Chiavassa, G
Dutto, L
Cannizzo, S
Bucca, C
Morello, M
Bergerone, S
Bardini, D
Zaccagna, A
Puiatti, P
Fava, C
Cortese, C
JOURNAL OF RHEUMATOLOGY, 2000, 27 (07) : 1693 - 1698
[38] Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension
Kharitonov, SA
Cailes, JB
Black, CM
duBois, RM
Barnes, PJ
THORAX, 1997, 52 (12) : 1051 - 1055
[39] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension
Ghofrani, HA
Pepke-Zaba, J
Barbera, JA
Channick, R
Keogh, AM
Gomez-Sanchez, MA
Kneussl, M
Grimminger, F
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 68S - 72S
[40] Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension
Crosswhite, Patrick
Sun, Zhongjie
JOURNAL OF HYPERTENSION, 2010, 28 (02) : 201 - 212

← 1 2 3 4 5 →